Manufacturing

Mar 29, 2015
By BioPharm International Editors
A consensus-based standard issued by NSF International incorporates regulatory and industry requirements into a single standard for the manufacturing and distribution of pharmaceutical excipients.
Mar 25, 2015
FDA has approved another indication for Eylea, a treatment for diabetic retinopathy in patients with diabetic macular edema.
BioPharm International: Mar 17, 2015
By BioPharm International Editors
WuXi's new US facility will manufacture CAR T-cell therapies and other cancer immunotherapies.
BioPharm International: Mar 03, 2015
By BioPharm International Editors
The upgrades will offer the opportunity for higher product yields and higher purity levels.
BioPharm International: Mar 01, 2015
Is there enough talent to go around?
Feb 23, 2015
By BioPharm International Editors
Leased facilities in California will expand Kite Pharma's capacity for T-cell therapies.
BioPharm International: Feb 20, 2015
MedImmune will provide funds and access to monoclonal antibodies to seven postdoctoral associates for the creation of protein measurement and characterization tools.
Feb 16, 2015
By BioPharm International Editors
Juno's new manufacturing facility in Washington state will support clinical trials for immunotherapies.
Feb 03, 2015
By BioPharm International Editors
The Shantha facility will be Sanofi's second, in addition to its site in Frankfurt, for production of Insuman insulin.
BioPharm International: Jan 29, 2015
By BioPharm International Editors
Catalent will add potent containment for blending and granulation at its New Jersey manufacturing Center of Excellence.